SCHWINK LOTHAR has a total of 11 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are VERNIER JEAN-MICHEL, Celon Pharma Sa and AUTIFONY THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Stengelin Siegfried | 11 |
#2 | Gossel Matthias | 11 |
#3 | Schwink Lothar | 11 |
#4 | Lennig Petra | 7 |
#5 | Hessler Gerhard | 7 |
#6 | Haack Torsten | 5 |
#7 | Wirth Klaus | 2 |
#8 | Kadereit Dieter | 1 |
#9 | Maier Thomas | 1 |
#10 | Boehme Thomas | 1 |
Publication | Filing date | Title |
---|---|---|
US2014099333A1 | Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders |